ScoreWhy is Beijing Beilu Pharmaceutical Co., Ltd. ?
1
With a growth in Operating Profit of 24.59%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 255.83 MM
- NET SALES(HY) At CNY 652.96 MM has Grown at 21.7%
- ROCE(HY) Highest at 6.18%
2
With ROE of 3.36%, it has a fair valuation with a 1.33 Price to Book Value
- Over the past year, while the stock has generated a return of -15.56%, its profits have risen by 775.5% ; the PEG ratio of the company is 0.1
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Beijing Beilu Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Beijing Beilu Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beijing Beilu Pharmaceutical Co., Ltd.
16.67%
1.70
47.41%
China Shanghai Composite
3.0%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.18%
EBIT Growth (5y)
-9.88%
EBIT to Interest (avg)
1.06
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.39
Tax Ratio
17.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.57%
ROE (avg)
2.68%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
54
Industry P/E
Price to Book Value
1.83
EV to EBIT
41.30
EV to EBITDA
23.15
EV to Capital Employed
1.89
EV to Sales
3.26
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
4.57%
ROE (Latest)
3.36%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 247.05 MM
ROCE(HY)
Highest at 6.8%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
DIVIDEND PAYOUT RATIO(Y)
Highest at 100%
DEBT-EQUITY RATIO
(HY)
Lowest at -10.48 %
INVENTORY TURNOVER RATIO(HY)
Highest at 1.9 times
DIVIDEND PER SHARE(HY)
Highest at CNY 4.99
NET SALES(Q)
Highest at CNY 352.96 MM
OPERATING PROFIT(Q)
Highest at CNY 71.9 MM
OPERATING PROFIT MARGIN(Q)
Highest at 20.37 %
PRE-TAX PROFIT(Q)
At CNY 46.6 MM has Grown at 99.66%
NET PROFIT(Q)
At CNY 35.31 MM has Grown at 78.66%
-2What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 15.36% (YoY
Here's what is working for Beijing Beilu Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 247.05 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 352.96 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 71.9 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 20.37 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
At CNY 46.6 MM has Grown at 99.66%
over average net sales of the previous four periods of CNY 23.34 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 35.31 MM has Grown at 78.66%
over average net sales of the previous four periods of CNY 19.76 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at -10.48 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 1.9 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Dividend per share
Highest at CNY 4.99
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CNY)
Dividend Payout Ratio
Highest at 100%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Depreciation
Highest at CNY 26.55 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (CNY MM)
Depreciation
At CNY 26.55 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (CNY MM)
Here's what is not working for Beijing Beilu Pharmaceutical Co., Ltd.
Raw Material Cost
Grown by 15.36% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
